Ligand validation:5GHO

8DG: 8-OXO-2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

8DG is a Ligand Of Interest in 5GHO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GHO_8DG_B_201	28%	14%	0.225	0.876	1.46	2.34	5	12	0	0	100%	1
6IJY_8DG_A_201	89%	31%	0.085	0.965	1.4	1.34	4	7	0	0	100%	1
8I18_8DG_A_201	89%	28%	0.083	0.962	1.34	1.53	5	7	0	0	100%	1
5GHI_8DG_A_201	85%	38%	0.092	0.958	0.86	1.53	1	7	0	0	100%	1
8I19_8DG_A_201	71%	13%	0.129	0.95	1.4	2.54	4	12	0	0	100%	1
5FSI_8DG_A_1157	34%	73%	0.171	0.854	0.36	0.68	-	1	0	0	100%	0.875
7KT3_8DG_A_501	98%	29%	0.058	0.984	1.24	1.57	4	5	0	0	100%	1
7KTJ_8DG_A_506	98%	43%	0.064	0.987	0.86	1.32	-	3	0	0	100%	1
5GG6_8DG_A_401	98%	8%	0.059	0.979	2.02	2.55	6	12	0	0	100%	1
5GG8_8DG_A_401	94%	6%	0.079	0.978	1.97	2.97	6	12	1	0	100%	1
7X9H_8DG_A_202	93%	22%	0.075	0.969	0.97	2.26	2	13	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.